- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01418469
Disturbances in BCAA Metabolism and the Effects of Feeding and Exercise in COPD
The Effects of Exercise on the Metabolic Fate of Branched Chain Amino Acids in Relation to Aging and Chronic Disease.
Studies on resting human muscle show that ingestion of the branched-chain amino acids (BCAA): leucine, valine and isoleucine have an anabolic effect on muscle protein metabolism. However, the effects of BCAA intake on protein metabolism during exercise are less clear. When BCAA were supplied as single amino acids, without other amino acids and/or carbohydrates, no effects were observed on protein kinetics. On the other hand, ingestion of BCAA during running appeared to reduce the catabolic effect of running on muscle protein metabolism. These experiments were all performed with mixtures of the BCAA with or without carbohydrates but not in the form of complete meals with food protein as a basis. Therefore, it is still unknown whether a protein meal, containing a substantial amount of BCAA is beneficial during exercise by inducing an anabolic effect.
Whey and Casein protein contain a substantial amount of BCAA in contrast to Soy protein. Therefore, it is hypothesized that milk-based proteins are a better and more physiological source of BCAA during exercise and will lead to more protein anabolism. Most of the available studies have been carried out in young and fit humans but there are hardly any data are available in the increasing population of the elderly. Therefore it is still unknown whether a BCAA rich protein meal can enhance the anabolic effect of exercise in older individuals.
Besides sarcopenia, a substantial part of the elderly is suffering from a chronic systemic disease such as chronic obstructive pulmonary disease (COPD). COPD represents an important health care problem. COPD is the fourth leading cause of death and will be the third leading cause worldwide in 2020. Besides the local impairment, COPD is a chronic wasting disease, associated with alterations in intermediary metabolism. Substantial disturbances have been found in BCAA (and related) metabolism in these patients at rest and during exercise. It might therefore be of clinical relevance to study the metabolic effects of BCAA rich protein meals in patients with COPD at rest and during exercise.
Study Overview
Status
Conditions
Detailed Description
In this study we investigate whether milk based protein sources of BCAA (casein and whey proteins) are superior to soy protein in the stimulation of protein anabolism before, during and after cycle exercise in COPD and healthy elderly and young subjects, and whether adding BCAA to soy protein will increase protein anabolism in these subjects.
To investigate Leucine, Isoleucine and Valine metabolism during and after exercise in COPD and healthy subjects
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Maastricht, Netherlands
- Maastricht UMC
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Irreversible chronic airflow limitation (FEV1 <70% of predicted)
- Clinically stable condition
Exclusion Criteria:
- Oxygen supplementation
- Respiratory tract infection or exacerbation of his disease at least 4 weeks prior to the study
- Oral corticosteroids as maintenance medication
- Other concomitant metabolic disease (ie malignancy, cardiac failure, recent surgery, severe endocrine, hepatic or renal disorder)
Study Plan
How is the study designed?
Design Details
- Allocation: RANDOMIZED
- Interventional Model: CROSSOVER
- Masking: DOUBLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: Caseinate protein intake
18 mg protein/kg body weight caseinate and 46 mg maltodextrin / kg body weight per 20 min sip feeding
|
18 mg protein/kg body weight caseinate and 46 mg maltodextrin / kg body weight per 20 min sip feeding
Other Names:
|
EXPERIMENTAL: Whey protein isolate intake
18 mg protein/kg body weight whey protein isolate and 46 mg maltodextrin / kg body weight per 20 min sip feeding
|
18 mg protein/kg body weight whey protein isolate and 46 mg maltodextrin / kg body weight per 20 min sip feeding
Other Names:
|
EXPERIMENTAL: Soy protein intake
18 mg protein/kg body weight soy and 46 mg maltodextrin / kg body weight per 20 min sip feeding
|
18 mg protein/kg body weight soy and 46 mg maltodextrin / kg body weight per 20 min sip feeding
|
EXPERIMENTAL: soy+BCAA protein intake
18 mg protein/kg body weight soy+BCAA and 46 mg maltodextrin / kg body weight per 20 min sip feeding
|
18 mg protein/kg body weight soy+BCAA and 46 mg maltodextrin / kg body weight per 20 min sip feeding
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in Net whole body protein synthesis
Time Frame: 6 hours
|
Net whole body protein synthesis during protein feeding and the response to a 20 min cycle exercise bout
|
6 hours
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in whole body protein synthesis rate
Time Frame: 6 hours
|
Whole body protein synthesis rate during protein feeding and the response to 20 min cycle exercise bout
|
6 hours
|
Change in Leucine turnover
Time Frame: 6 hours
|
Leucine turnover during protein feeding and the response to a 20 min cycle exercise bout
|
6 hours
|
Change in Isoleucine turnover
Time Frame: 6 hours
|
Isoleucine turnover during protein feeding and the response to a 20 min cycle exercise bout
|
6 hours
|
Change in Valine turnover
Time Frame: 6 hours
|
Valine turnover during protein feeding and the response to a 20 min cycle exercise bout
|
6 hours
|
Change in plasma lactate concentration
Time Frame: 6 hours
|
Plasma lactate during protein feeding and the response to a 20 min cycle exercise bout
|
6 hours
|
Change in NH3 concentration
Time Frame: 6 hours
|
Plasma NH3 during protein feeding and the response to a 20 min cycle exercise bout
|
6 hours
|
Change in plasma amino acids concentrations
Time Frame: 6 hours
|
Plasma amino acid concentrations during protein feeding and the response to a 20 min cycle exercise bout
|
6 hours
|
Splanchnic extraction of amino acids during protein feeding
Time Frame: 6 hours
|
Splanchnic extraction of amino acids during protein feeding and the response to a 20 min cycle exercise bout
|
6 hours
|
Change in whole body protein breakdown rate
Time Frame: 6 hours
|
Whole body protein breakdown rate during protein feeding and the response to cycle exercise
|
6 hours
|
Collaborators and Investigators
Collaborators
Publications and helpful links
General Publications
- Engelen MP, Rutten EP, De Castro CL, Wouters EF, Schols AM, Deutz NE. Supplementation of soy protein with branched-chain amino acids alters protein metabolism in healthy elderly and even more in patients with chronic obstructive pulmonary disease. Am J Clin Nutr. 2007 Feb;85(2):431-9. doi: 10.1093/ajcn/85.2.431.
- Engelen MP, Rutten EP, De Castro CL, Wouters EF, Schols AM, Deutz NE. Altered interorgan response to feeding in patients with chronic obstructive pulmonary disease. Am J Clin Nutr. 2005 Aug;82(2):366-72. doi: 10.1093/ajcn.82.2.366.
- Engelen MP, De Castro CL, Rutten EP, Wouters EF, Schols AM, Deutz NE. Enhanced anabolic response to milk protein sip feeding in elderly subjects with COPD is associated with a reduced splanchnic extraction of multiple amino acids. Clin Nutr. 2012 Oct;31(5):616-24. doi: 10.1016/j.clnu.2012.04.006. Epub 2012 Jun 6.
- Engelen MP, Rutten EP, De Castro CL, Wouters EF, Schols AM, Deutz NE. Casein protein results in higher prandial and exercise induced whole body protein anabolism than whey protein in chronic obstructive pulmonary disease. Metabolism. 2012 Sep;61(9):1289-300. doi: 10.1016/j.metabol.2012.03.001. Epub 2012 Apr 17.
Study record dates
Study Major Dates
Study Start
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ESTIMATE)
Study Record Updates
Last Update Posted (ESTIMATE)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- MEC 02-059.3
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Chronic Obstructive Pulmonary Disease
-
Spire, Inc.ResMedCompletedSevere Chronic Obstructive Pulmonary Disease | Moderate Chronic Obstructive Pulmonary DiseaseUnited States
-
Karaganda Medical UniversityCompletedChronic Obstructive Pulmonary Disease | Chronic Obstructive Pulmonary Disease Moderate | Chronic Obstructive Pulmonary Disease SevereKazakhstan
-
Randall DebattistaUniversity of Malta, Faculty of Health SciencesNot yet recruitingChronic Obstructive Pulmonary Disease Moderate | Acute Exacerbation of COPD | Chronic Obstructive Pulmonary Disease Severe
-
Cukurova UniversityCompletedAnesthesia | Chronic Obstructive Pulmonary Disease Moderate | Lungcancer | Chronic Obstructive Pulmonary Disease Severe | Chronic Obstructive Pulmonary Disease MildTurkey
-
National Taipei University of Nursing and Health...TerminatedChronic Pulmonary Disease | Chronic Obstructive Pulmonary Disease Exacerbation | Chronic Obstructive Pulmonary Disease With ExacerbationTaiwan
-
Taipei Medical UniversityUnknownChronic Obstructive Pulmonary Disease Severe | Chronic Obstructive Pulmonary Disease End StageTaiwan
-
Kırıkkale UniversityRecruitingCOPD (Chronic Obstructive Pulmonary Disease)Turkey
-
Hopital FochAir Liquide SARecruitingChronic Obstructive Pulmonary Disease SevereFrance
-
Fundación para la Investigación del Hospital Clínico...Not yet recruitingCOPD, Chronic Obstructive Pulmonary DiseaseSpain
-
Canandaigua VA Medical CenterRecruitingChronic Obstructive Pulmonary Disease ModerateUnited States
Clinical Trials on Caseinate
-
Christian HvasCompletedShort Bowel Syndrome | Nutritional Deficiency | Ileostomy; Functional Disturbance | Absorption; Disorder, ProteinDenmark
-
University College CorkCompleted
-
University of ReadingVolac Int. Ltd.Completed
-
Hospital General de MexicoUnknownWound Healing | DiabeticMexico
-
NIZO Food ResearchFrieslandCampinaCompleted
-
Purdue UniversityCompletedAppetitive BehaviorUnited States
-
Ohio State UniversityCompletedPrediabetesUnited States
-
Assiut UniversityCompletedHeavy Menstrual Bleeding | Improve Quality of LifeEgypt